The heart of resiliency in veterinary medicine – DVM 360

Resiliencythe ability to recover from setbacks, adapt well to change, and keep going in the face of adversityis a hot topic in veterinary medicine today. Although we need to be cognizant of client emotions, we must also care for ourselves and our team. In a recent survey, more than 70% of veterinarians reported that both they and their staff felt moderate to severe distress when faced with obstacles that prevented them from providing appropriate patient care.1Acknowledging these feelings and discussing them with coworkers, family, or a professional is essential to maintaining well-being and providing the best patient and client care.

A common misconception among veterinary professionals is that if we were truly resilient, we would not experience the intense emotions inherent in this profession. This way of thinking could not be further from the truth. Allowing yourself to feel every emotion and still function daily is at the heart of resiliency in veterinary medicine and vitally important as an individual. Permitting ourselves to feel and process what makes us who we are is the next step in mastering true resiliency.

Regardless of individual roles, the pandemic has pushed everyone in veterinary practices to support patients and communities through creativity and collective problem-solving. In addition to unprecedented caseloads, teams have been navigating new protocols to protect associates, clients, and patients and still provide excellent care. These new approaches to triage, reallocation of staff, and changes in patient care have led to amazing innovation throughout the industry, but doing so has come at the cost of increased burnout.

The initial crisis rally and altruism faded over the course of 2020 due to understandable fatigue. You may have succumbed to the various crises you faced, with varying capacities to adapt and cope. Dont worry; no one was untouched by persistent anxiety or the need to repeatedly adjust their normal routines and ways of thinking.

We are currently operating in survival mode. Our blinders are more likely to be up, making it challenging to see the bigger picture or to have an optimistic perspective. When in this self-protective mode, energy and time can feel scarce. Anger, frustration, and resentment can overshadow our ability to find the positive in situations. Survival mode has become a defense mechanism, creating a protective, insulating barrier between you and the world. Feeling alone and overwhelmed may result in intense feelings of isolation.

Survival mode can also exacerbate preexisting tensions, such as the us versus them phenomenon of the front desk team versus treatment team, emergency clinicians versus specialty clinicians, associates versus leaders, and even more. Compassionate, respectful communication among teammates is paramount to providing high-quality patient and client care. Building a sense of community can also create a more fulfilling work environment. Without it, we may be more likely to self-sabotage and interact negatively with colleagues.

When you feel like you have to just get through it or no one will understand, you might respond negatively to a conversation about building resilience. Veterinary medicine has a longstanding culture of I should be able to handle this, and there are stigmas and fears of being judged and deemed inadequate if we demonstrate that were struggling. This mindset hinders our ability to access the mental health care that we may need.

Practice leadership must take responsibility for creating an environment that promotes well-being and safety. It takes resilient individuals to build a resilient community. This community can only thrive if there is clear evidence that leadership is doing their part to cultivate a less toxic environment and culture.

Are your practice leaders promoting conversation and resource allocation that supports staff well-being? Does your team feel that their well-being is a priority, or do they have the perception that decisions are motivated by profit? If you believe your practice culture to be people-driven, what conversations and initiatives are being actively supported to demonstrate this belief? How do values of respect and care for individual associates show up in the practice?

It is human nature to want any pain to go away quickly. We do not like being uncomfortable physically, emotionally, or psychologically. There is no quick fix that can magically transform our work environments, but there is more inherent wisdom and resilience in each of us than we give ourselves credit for.

So, how do we save ourselves and our profession in the face of so much pessimism and exhaustion? Here are a few ideas you can implement to combat these negative feelings:

Lori Harbert, LCSW, a social worker for more than 20 years, specializes in mental health counseling, trauma-informed care, crisis counseling, grief and bereavement counseling, and leadership building. She developed and launched BluePearls first health and well-being program that provides resources and support to more than 6000 associates.

Sonja Olson, DVM, is a full-time wellness educator with the BluePearl health and well-being team, where she educates EmERge program clinicians, BluePearl associates, and regional social workers about wellness topics. She is also certified as a mental health First Aid instructor and compassion fatigue educator with Green Cross Academy of Traumatology's Figley Institute.

Reference

1. Moses L, Malowney MJ, Wesley Boyd J. Ethical conflict and moral distress in veterinary practice: a survey of North American veterinarians. J Vet Intern Med. 2018;32(6):2115-2122. doi:10.1111/jvim.15315

View original post here:

The heart of resiliency in veterinary medicine - DVM 360

Axonics to Participate in the Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2021 Winter Meeting – BioSpace

Feb. 18, 2021 11:00 UTC

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, today announced it is participating as a platinum sponsor of the Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) 2021 Winter Meeting, which is being held virtually from February 25-27.

Axonics is sponsoring a symposium on Saturday, February 27, titled A New Era in Sacral Neuromodulation. During the symposium, a panel of physicians will discuss how recent innovations in SNM technology are changing the practice of how physicians treat patients with bladder and bowel dysfunction. The symposium will be available after the meeting for viewing at http://www.axonicswebinars.com.

In addition to participating in the virtual exhibit hall and symposium, the two-year results of the ARTISAN-SNM study will be presented at a plenary session on Saturday, February 27, by Andrea Pezzella, M.D, FPMRS, FACOG, of South Urogynecology and a study investigator of the pivotal study. Additionally, a detailed analysis of patient satisfaction in the ARTISAN-SNM study will be presented on the same day in a poster session by Julia Geynisman-Tan, M.D., FACOG, of Northwestern University.

The SUFU 2021 Winter Meeting provides an opportunity for physicians using the Axonics System to share their positive experience and strong clinical results with their peers, said John Woock, Ph.D., chief marketing officer of Axonics. As a platinum sponsor of the conference, Axonics is providing numerous opportunities for physicians to learn more about the Axonics System. We believe physicians sharing the exceptional experience their patients are having with our new SNM technology will encourage further utilization, drive market expansion and result in Axonics SNM therapy becoming the preferred solution for urinary and bowel dysfunction.

About Axonics Modulation Technologies, Inc.

Axonics, based in Irvine, Calif., has developed and is commercializing novel implantable SNM devices for patients with urinary and bowel dysfunction. These conditions are caused by a miscommunication between the bladder and the brain and significantly impacts quality of life. Overactive bladder affects an estimated 87 million adults in the U.S. and Europe. Another estimated 40 million adults are reported to suffer from fecal incontinence/accidental bowel leakage. Axonics SNM therapy, which has been clinically proven to reduce symptoms and restore pelvic floor function, is now being offered at hundreds of medical centers across the U.S. and in dozens of select hospitals in Western Europe. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. The Axonics System is the first long-lived rechargeable SNM system approved for sale in the world, and the first to gain full-body MRI conditional labeling. For more information, visit http://www.axonics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005072/en/

Follow this link:

Axonics to Participate in the Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2021 Winter Meeting - BioSpace

Global Medicine Decoction and Packing Machines Market is to Witness Significant Growth between 2020-2026 with leading players Shandong Sanming…

According to Zeal Insider, the Medicine Decoction and Packing Machines market was at valued at US$ xx million in 2019 and is anticipated to rise at a CAGR of xx% during the forecast period from 2020 to 2028. The report on the Medicine Decoction and Packing Machines market compromises in-depth analysis covering key regional trends, market dynamics, and provides country-level market size of the Medicine Decoction and Packing Machines industry. Some of the major aspects considered during the course of research included product description, product classification, industry structure, various participants in the Medicine Decoction and Packing Machines market, etc. The report provides actual market values for 2018 and 2019 along with forecasts for the period from 2020 to 2028, and CAGR % measured for individual segments and regional markets.

Our best analysts have surveyed the market report with the reference of inventories and data given by the key players:

Download Sample Copy of Medicine Decoction and Packing Machines Market Report Study 2019-2026 At: https://www.zealinsider.com/report/165864/medicine-decoction-and-packing-machines-market#sample

The report focuses on global companies operating in the Medicine Decoction and Packing Machines market providing data points such as company profiles, product picture and description, capacity, production, value, revenue and contact information. This research offers key statistics on the state of the industry and is an important source of guidance and direction for companies and individuals involved in the market. Along with CAGR forecasts, various other parameters like Y-o-Y Medicine Decoction and Packing Machines market growth, qualitative and quantitative insights are presented. The key points such as market size, value, volume, product portfolio, explanation and classification of Medicine Decoction and Packing Machines market are stated. Also, the current trends, technological progressions in Medicine Decoction and Packing Machines market, are explained.

Market Overview of Covid-19 Outbreak:

This report offers information that help to know which market segment or region or country to emphasis in coming years to channelize their efforts and investment to maximize growth and profitability. The report delivers market competitive landscape and a consistent detailed study of the major players in the market along with economic slowdown because of COVID-19.

Some of The Key Aspects Covered in This Report:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.zealinsider.com/report/165864/medicine-decoction-and-packing-machines-market#inquiry

Medicine Decoction and Packing Machines Market Segmentation:

The report compromises detailed study of the Medicine Decoction and Packing Machines market based on various segments such as type, application and end-use industry. The Medicine Decoction and Packing Machines market is segmented as follows:

Medicine Decoction and Packing Machines Market, by Type:

Medicine Decoction and Packing Machines Market, by Application:

Geographic Coverage

The report on the Medicine Decoction and Packing Machines market provides a detailed of the geographical segmentation which mainly focuses on current and forecast demand for Medicine Decoction and Packing Machines in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further emphases on demand for individual application segments in all the regions The report covers comprehensive market size and forecast for the following countries and regions:

North America Medicine Decoction and Packing Machines Market Revenue and Forecast

Europe Medicine Decoction and Packing Machines Market Revenue and Forecast

Asia Pacific Medicine Decoction and Packing Machines Market Revenue and Forecast

Latin America Medicine Decoction and Packing Machines Market Revenue and Forecast

Middle East and Africa Medicine Decoction and Packing Machines Market Revenue and Forecast

Buy single user with discounted price now: https://www.zealinsider.com/checkout?reportId=165864&&usert=su

About Us:

We at Zeal Insider aim to be global leaders in qualitative and predictive analysis as we put ourselves in the front seat for identifying worldwide industrial trends and opportunities and mapping them out for you on a silver platter. We specialize in identifying the calibers of the markets robust activities and constantly pushing out the areas which allow our clientele base in making the most innovative, optimized, integrated and strategic business decisions in order to put them ahead of their competition by leaps and bounds. Our researchers achieve this mammoth of a task by conducting sound research through many data points scattered through carefully placed equatorial regions.

Contact Us:

Zeal Insider1st Floor, Harikrishna Building,Samarth Nagar, New Sanghvi,Pune- 411027 Indiatel: +91-8149441100 (GMT Office Hours)tel: +17738002974sales@zealinsider.com

Originally posted here:

Global Medicine Decoction and Packing Machines Market is to Witness Significant Growth between 2020-2026 with leading players Shandong Sanming...

Thunder Bay Therapy and Sports Medicine to get new look, new name – Alpena News

News Photo by Crystal NelsonThunder Bay Therapy and Sports Medicine owners Teresa and Bruce Duncan demonstrate their balancing equipment earlier this month at the location in Alpena.

ALPENA Thunder Bay Therapy and Sports Medicine will be unveiling a new look this spring, after joining forces with a nationally renowned physical therapy franchise.

Owners Bruce and Teresa Duncan recently signed an agreement with Fyzical Therapy and Balance Centers. The company has more than 400 locations throughout the United States, Teresa Duncan said, with the closest franchises currently located in Petoskey and Traverse City.

The business will be changing its name to Thunder Bay Fyzical Therapy and Balance Centers as part of the agreement, but the Duncans will retain ownership, and all of their employees will continue to work there.

Bruce Duncan said Fyzical Therapy and Balance Centers will provide more supportive services, which will provide them with more advanced training in both the clinical and business side of operations.

One of the issues weve run into for probably the last five years, its become increasingly complex of a landscape and we really needed a partner to help us through some of the regulatory issues that are part of health care, he said.

He said Fyzical was really the only option that worked for them, because the group offered them help. Other franchises would have bought their business and taken it over, which is not what the Duncans wanted.

Additionally, he said they wanted to maintain their independence so they can treat people in the manner they find best.

It was very important to us that we be able to retain ownership and all decision making and Fyzical met that need, Teresa Duncan said. It was also very important that we be able to grow this even more so it lasts a very time both for our community and for our employees.

Bruce Duncan said Thunder Bay Therapy already does some balance work, but they found Fyzical offered both training on the clinical end and on the business end to expand what they do for balance and distribution care.

The additional training for balance and distribution care is just one of the areas Fyzical will help the business expand into. Teresa Duncan said they want to become the place that people think of when they need specialized physical therapy or sports medicine.

The Duncans said they originally planned to go public with the change in the summer, but the coronavirus pandemic slowed their plans down terribly.

In the meantime, Teresa Duncan said the business changed its paint scheme to match the new branding. Theyve also received new equipment and staff have been attending clinical training. She said she expects the new signage to go up just after the first of the year.

Bruce Duncan said the agreement with Fyzical will allow the business to continue to move forward and meet the Duncans goals.

As weve grown, we want to expand services into areas that people normally have to go downstate for, or across the state for, he said. We really want to become a center of excellence, where people say, Im going to Alpena because they have this clinic, as opposed to, well get the basics here and then go down to Ann Arbor.'

Today's breaking news and more in your inbox

See the original post here:

Thunder Bay Therapy and Sports Medicine to get new look, new name - Alpena News

Bedford psychiatrist to keep his license after Board of Medicine rescinds revocation – The Union Leader

Eleven months after revoking the license of a Bedford psychiatrist, the New Hampshire Board of Medicine last month reversed itself and agreed with lawyers for Dr. Jayakumar Patil that he can continue his practice.

The turnabout comes after nearly a year of legal maneuvers since Jan. 10, when the board took the unusual step of ordering the license revocation of a psychiatrist with a history of 31 years of practice in the state.

The revocation order, which was never implemented, represented the fourth time that Patil had appeared before the board for disciplinary matters.

In discussions with a Union Leader reporter last week, Patil likened himself to the speeding driver who gets pulled over on a highway where everyone else is speeding. He said he would speak to a reporter after contacting his lawyer.

The following day, the media department of Bernstein Shur issued a statement with Patils name attached: I am truly grateful to all of my patients and my fellow colleagues for their strong support during this time, which meant a lot to me and my family. I am pleased with the resolution we reached with the Board of Medicine, and I appreciate their thoughtful deliberation in this matter.

Efforts to obtain an interview with the Board of Medicine member who presided over the case were unsuccessful.

The revocation order came as New Hampshire struggled, and continues to struggle, with a shortage of psychiatrists and other mental health workers.

Dr. Patrick Ho, a psychiatrist in the Upper Valley and president of the New Hampshire Psychiatric Society, said it can take months for a person to get an initial appointment or follow-up appointment with a psychiatrist.

That backlog is manifested in societal problems of drug abuse and homelessness, he said.

I dont know what (the board) was thinking, but Im sure theyre aware of the context and that definitely provides a backdrop, said Ho, who said hes never met Patil.

Ho said he was bothered to hear the analogy about the one speeder punished among many. He said psychiatrists are expected to adhere to evidence-based standards of care in the profession.

In January, the board found that Patil violated professional standards seven times in the treatment of a man identified as C.C. in 2017. That treatment including prescribing stimulants to a man with an elevated heart rate represented a danger to the patient and did not meet the standards of psychiatric care, the board said in its findings.

Given these circumstances, and give Dr. Patils past history with the Board, the Board finds revocation the appropriate level of discipline, the board wrote in its Jan. 10 order.

It was the fourth time Patil had gone before the board. Each of the other three times resulted in settlement agreements that called for fines.

Patils lawyers filed papers complaining that the C.C. complaint dealt with a period before Patil was working with a board-ordered mentor. Lawyers challenged the credentials of an expert who criticized Patils work. And the lawyers said some board members appeared to be dozing during the revocation hearing.

In the settlement agreement dated last month, the board said it agreed to allow Patil to keep his license in order to avoid the delay and expense of further proceedings and to promote the best interests of the public and the practice of medicine.

A five-year probationary period that includes monthly meetings with a mentor, Dr. Leonard Korn, to review patient records and discuss clinical treatment.

Thirty hours of unspecified course work.

An initial, six-month period in which Patil can see no more than 15 patients a day.

Status hearings before the Board of Medicine, but the ability to end probation after three years.

Written evaluations from Korn.

An independent review of patient records.

In January, Patil asked patients to write the Board of Medicine on his behalf. Colleagues also did so, according to a sample that the board administrators provided to the Union Leader at the time.

A former investigator with the Board of Medicine, Alexis Wallace, noted the nationwide shortage of psychiatrists. When many clients were faced with long waits, Patil expedited intakes and often worked late nights and on weekends, Wallace wrote.

Dr. John Miller, a psychiatrist at Seacoast Mental Health Center in Exeter Hospital, called Patil thoughtful, compassionate and skilled.

Dr. Patil listens and researches what is best for patients, wrote a patient, Mariam Banash. He is more responsive than any other psychiatrist Ive ever seen.

Hutton Snow said he is 73 and on Medicare, and Patil is the only psychiatrist he knows who will accept Medicare.

I personally find him competent, caring, approachable, and (it is) extremely important to allow him to remain in practice, Snow said. There are 900+ patients depending on his care.

View post:

Bedford psychiatrist to keep his license after Board of Medicine rescinds revocation - The Union Leader

New Discoveries Will Increase the Effectiveness of Magnetic Fluids in Medicine – SciTechDaily

Scientists take a step towards expanding the use of magnetic fluids in medicine and technology. Credit: Peter the Great St. Petersburg Polytechnic University

Researchers discovered new effects in magnetic fluids, which will increase its effectiveness for medical purposes.

Magnetic fluids are used in many different areas, including medicine, electronics, mechanical engineering, ecology, etc. Such a wide range of applications is explained by a number of its useful properties. Researchers from Peter the Great St.Petersburg Polytechnic University (SPbPU) in collaboration with colleagues from Jiangsu Normal University (JSNU) discovered new effects in magnetic fluids, which will increase its effectiveness for medical purposes in future. The results were published in Springer Proceedings in Physics.

Magnetic fluids can be used, for example, in surgery. If a magnetic fluid is injected into a vein or artery, and a permanent magnet is located in the place of the incision, a plug of the magnetic fluid will block the blood flow after the incision. These magnetic fluids are naturally diluted in the body fluids, which leads to the formation of the large aggregates and its eventual deposition. It may result in capillary blockage and other negative effects. In this regard, it is important to investigate the aggregation stability during dilution in order to prevent the sticking of particles, said Elina Nepomnyashchaya, an employee of the Laboratory for Laser Photometry and Spectroscopy SPbPU.

In normal conditions various stabilizations are used to prevent the sticking of particles in the magnetic fluids. The scientific group of the Polytechnic University used the spectral analysis in the visible and ultraviolet range and assessed the stability of the magnetic fluids. Such research for described particles has never been conducted before. Mostly the studies in this field are dedicated to the infrared range, due to the possibility of implementation of the magnetic fluids in the optical fiber lines.

However, the studies in the visible and ultraviolet range could be useful to evaluate the optical properties of particles in the magnetic fluids and to detect their aggregations, which occurs if the stability is disturbed due to the dilution.

Currently, the scientific group is working on the method of magnetic fluids stabilization, which could be safely used in medicine. Researchers are to determine the safe composition and concentration of the magnetic fluids for medical purposes.

In the future, such studies will be aimed at assessing the aggregation stability of magnetic fluids in case of the dilution and upon the influence of the magnetic field used to deliver particles in the body.

See the article here:

New Discoveries Will Increase the Effectiveness of Magnetic Fluids in Medicine - SciTechDaily

Vertex Announces New Drug Submission for Investigational Triple Combination Medicine for the Treatment of Cystic Fibrosis Has Been Accepted for…

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced its New Drug Submission for TRIKAFTA, Vertexs investigational triple combination medicine, has been accepted for Priority Review by Health Canada for the treatment of cystic fibrosis (CF) in people ages 12 years and older.

We are pleased this submission has been accepted for Priority Review by Health Canada, and we anticipate this accelerated review process will enable access for patients as early as possible, said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer at Vertex.

With Priority Review, the conventional review timeline of 300 days is reduced to 180 days. The expected approval target by Health Canada is in the first half of 2021.

About Cystic Fibrosis

Cystic fibrosis (CF) is a rare, life-shortening genetic disease affecting approximately 75,000 people worldwide. CF is a progressive, multi-system disease that affects the lungs, liver, GI tract, sinuses, sweat glands, pancreas and reproductive tract. CF is caused by a defective and/or missing CFTR protein resulting from certain mutations in the CFTR gene. Children must inherit two defective CFTR genes one from each parent to have CF. While there are many different types of CFTR mutations that can cause the disease, the vast majority of all people with CF have at least one F508del mutation. These mutations, which can be determined by a genetic test, or genotyping test, lead to CF by creating non-working and/or too few CFTR proteins at the cell surface. The defective function and/or absence of CFTR protein results in poor flow of salt and water into and out of the cells in a number of organs. In the lungs, this leads to the buildup of abnormally thick, sticky mucus that can cause chronic lung infections and progressive lung damage in many patients that eventually leads to death. The median age of death is in the early 30s.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create medicines for people with serious diseases. The company has multiple approved medicines that treat cystic fibrosis (CF) a rare, life- threatening genetic disease and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, Vertex has a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus.

Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 11 consecutive years on Science magazine's Top Employers list and a best place to work for LGBTQ equality by the Human Rights Campaign. For company updates and to learn more about Vertexs history of innovation, visit http://www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

Special Note Regarding Forward-Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, statements made by Carmen Bozic in this press release, including expectations for patient access to our medicine, and statements regarding the anticipated timing of the expected approval target by Health Canada. While Vertex believes the forward-looking statements contained in this press release are accurate, these forward-looking statements represent the company's beliefs only as of the date of this press release and there are a number of risks and uncertainties that could cause actual events or results to differ materially from those expressed or implied by such forward-looking statements. Those risks and uncertainties include, among other things, that the New Drug Submission to Health Canada may not be approved in the expected timeline, or at all, that data from the company's development programs may not support registration or further development of its compounds due to safety, efficacy or other reasons, and other risks listed under the heading Risk Factors in Vertex's most recent annual report and subsequent quarterly reports filed with the Securities and Exchange Commission at http://www.sec.gov and available through the company's website at http://www.vrtx.com. You should not place undue reliance on these statements. Vertex disclaims any obligation to update the information contained in this press release as new information becomes available.

(VRTX-GEN)

Originally posted here:

Vertex Announces New Drug Submission for Investigational Triple Combination Medicine for the Treatment of Cystic Fibrosis Has Been Accepted for...

The breakthrough medicines that could change the course of Covid – The Guardian

It remains one of the most dramatically successful outcomes in the battle against Covid-19. A cheap treatment for inflammation was found to save lives of seriously ill patients while a trio of much-touted therapies were shown to have no effect.

It is now estimated that the discovery of the effectiveness of the drug dexamethasone has saved around 650,000 lives across the world, according to Professor Martin Landray, a founder of the Recovery programme the worlds largest randomised Covid-19 drugs trial which revealed the medicines anti-Covid properties last summer. In the UK alone, dexamethasone has already prevented more than 12,000 deaths, he told the Observer.

The breakthrough demonstrates the power of large-scale randomised trials in pinpointing effective medicines and will be followed, in the next few weeks, with results from another handful of promising treatments being studied as part of the Recovery programme.

These medicines, which could be crucial in the fight to contain Covid-19 next year, are: convalescent plasma, taken from recovering Covid patients; monoclonal antibodies, made by Regeneron, that were used to treat Donald Trump; two anti-inflammatory drugs, tocilizumab and colchicine; and aspirin. All are undergoing trials carried out by thousands of doctors and nurses on tens of thousands of patients in hospitals across Britain. First results are expected in January or early February.

Recovery was set up by Landray and Peter Horby at the start of the Covid-19 pandemic. The two Oxford scientists realised doctors would soon be looking for treatments once cases started pouring into hospitals but would need a clinical trial to find which were effective. It took them nine days from drafting their first protocol to the enrolling of their first patient, a process that normally takes nine months. One in 10 patients hospitalised with Covid have since entered the trial.

And such numbers have been crucial to success, added Landray. Comparing 100 people who get a drug with 100 who do not can produce highly variable results. However, by randomising thousands of patients to get contrasting treatments, robust answers are produced.

You find out which actually work, said Landray. In addition, we can discover which patients will benefit most. Will it be the old or the young or the immuno-compromised? You can only find that out if you have a trial with thousands of people in it.

So far, Recovery short for Randomised Evaluation of Covid-19 Therapy has pronounced on four medicines: azithromycin, an antibiotic; the drug combination lopinavir-ritonavir; hydroxychloroquine, a treatment for malaria and rheumatic diseases; and dexamethasone. Only the last saved lives or aided recovery.

A hit rate of only one in four might seem poor value. However, the extraordinary numbers of lives saved thanks to dexamethasone demonstrates the value of the Recovery programme, the worlds largest randomised Covid-19 drug trial. The programme also ensured time and money have not been wasted on medicines that were found not to help patients.

And that will become an increasingly important issue, Landray said. When we started Recovery we looked at cheap, widely available but promising drugs, and found one of them dexamethasone worked. But the medicines were looking at now will cost hundreds of pounds per treatment, so we need to be really sure they work before we deploy them on wide scale, Landray said.

Having thousands of individuals with Covid-19 complications is a grim reality in the UK at present, but that high number at least makes it possible to run large-scale trials.

However there is a limit to what doctors and nurses can be expected to do, added Lanray.

We designed this study to be as simple to implement as possible so as not to overwhelm busy frontline NHS staff. The support from them and patients has been remarkable. Our results have improved Covid care for millions. The answers we get early next year, whatever they are, will do so again.

Convalescent blood plasma is taken from those recovering from Covid-19 and has antibodies that may help others fight infections. Widely used in the US though scientists dont yet know if it works or who would benefit most from it. The Recovery programme should have answers in a few weeks.

Monoclonal antibodies are artificial antibodies made by the US biotech company Regeneron and were used to treat Donald Trump. It is not yet clear at which stage of illness they should be administered.

Tocilizumab is an anti-inflammatory arthritis drug thought to hold considerable promise, though its exact benefits are unknown. It is also costly.

Colchicine is another promising anti-inflammatory drug; often used to treat gout.

Aspirin is a blood-thinning agent which could help reduce blood clots in the lungs a worrying complication in some Covid-19 cases.

Continue reading here:

The breakthrough medicines that could change the course of Covid - The Guardian

Regenerative Medicine in Pharma 2020 – Opportunities, Challenges, and Unmet Needs – GlobeNewswire

Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Regenerative Medicine in Pharma - Thematic Research" report has been added to ResearchAndMarkets.com's offering.

Regenerative medicine is a multidisciplinary field that seeks to develop the science and tools that can help repair, augment, replace, or regenerate damaged or diseased human cells, tissues, genes, organs, or metabolic processes, to restore normal function. It may involve the transplantation of stem cells, progenitor cells, or tissue, stimulation of the body's own repair mechanisms, or the use of cells as delivery vehicles for therapeutic agents such as genes and cytokines.

It is widely anticipated that Gene therapy is the most valuable regenerative medicine sector however, this market is also expected to be slowed down by high cost of therapies, which may limit its accessibility.Existing programs will facilitate the approval and development of regenerative medicines, however, a reimbursement system especially for curative therapies is warranted.

The Regenerative Medicine in Pharma report combines primary research from a cross-specialty panel of experts with in-house analyst expertise to provide an assessment of the development landscape.

This report assesses -

Scope

Key Topics Covered:

For more information about this report visit https://www.researchandmarkets.com/r/7trz9r

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Go here to see the original:

Regenerative Medicine in Pharma 2020 - Opportunities, Challenges, and Unmet Needs - GlobeNewswire

SPORTS MEDICINE: Years will pass before medical view of 2020 is fully focused – The Times of Northwest Indiana

The Panthers Kawann Short, an E.C. Central grad, has played a key role on the defensive line.

The big, bold and colorful mural on the outside wall of Columbus Drive Gyros hits you like a storm surge while entering the building.

Its a life-size painting of hometown hero Kawann Short, defensive tackle for the Carolina Panthers, in his No. 99 uniform and holding the Super Bowl 50 trophy triumphantly in his right hand, an event that was not to be.

Throughout Northwest Indiana, there were banners, posters and pep rallies throughout the city in support of the E.C. Central grad. Social media kept him in touch daily with the Region, as if he were standing at the corner of Chicago Avenue and Indianapolis Boulevard, taking it all in.

One particular banner stretched across Columbus Drive at Alder Street, proclaimed: East Chicago is proud of our hometown Kawann Short. We are East Chicago Super Bowl 50. Go Panthers!

That 10-by-10-foot mural at Columbus Drive Gyros was painted Jan. 28 by the artist known as Fhat Cousins, who worked on his labor of love for eight hours.

Im 6-foot, and I still have to look up at it, said restaurant owner John Troupis. Its a win-win for the city because it went viral on social media. People are always pulling up, taking pictures of it.

Kawann loved it and ended up sharing it (on social media). It lit a fire under everybody to join the celebrating.

E.C. Central and middle school football players watched the 2016 Super Bowl in the high schools mini-theater, with a pre-game video message delivered by Kawann Short.

Ive seen so much of the love coming from home. Its sincere and coming from the heart, he said by phone prior to the game. East Chicago isnt very big. It has only about 30,000 but they respect people who get out and do things with their lives.

And when you do, they gladly jump on board and support you 100 percent.

The 44th overall pick in the 2013 draft, Short went from five sacks combined over his first two seasons to an eye-popping 11 in 2105-16 a team record for defensive tackles before the NFL championship game.

But what really jumps out to students of the game is 11 sacks, 55 tackles and three forced fumbles by a 4-3 interior lineman who also is a fierce pass rusher on the edge.

Short has transformed from a player who flashed across the screen once a game to a surefire Pro Bowler.

Im just out here doing what Im doing and trying to help this team win. Its the only thing I can ask or work for, said the 6-foot-3, 315-pound Short.

Short has partnered with Athletes for Charity, HealthLinc and the East Chicago Fire and Police Departments to create academic incentives to benefit youth. Hes launched a Youth Literacy Project to deliver books and academic incentives to children in need of encouragement when it comes to reading and academic achievement.

They always come back. Theyve never forgotten about their city and thats whats so great, said Steve Segura, multimedia director of East Chicago.

Getting involved, sending a positive message, can work wonders in any environment.

Some guys play this game 16-17 years and havent been to the Super Bowl. Ive played three years and Im here, said Short, who had a video message for the citys football players watching Super Bowl 50 game at the high school:

Ive been in your position and in the same seats many years ago. I had a vision and a dream to be where I am today, Short said. East Chicago ... you guys have been behind my back 100 percent. I appreciate you guys for being there, showing love and support. Youve been amazing. Have a blessed day.

As kids, ETwaun Moore and Short often stopped at Columbus Drive Gyros for a quick bite after school. It was a popular hangout with their basketball teammates.

ETwaun was the star point guard and Kawann a power forward on the Cardinals 2006-07 team. Owner John Troupis recalled how the players, prior to sectionals, had assured him they were going to win the 4A championship.

He made a deal. Win state and its all you can eat.

The Cardinals advanced through the tourney knocking off Lowell, Munster, South Bend Adams, Valparaiso and Marion for a shot at Indianapolis North Central, featuring high school phenom Eric Gordon.

E.C. Central prevailed, 87-83.

It wasnt long after when Moore and Short, holding the trophy, led the Cardinals into Columbus Drive Gyros and said: Were really hungry!

See the original post:

SPORTS MEDICINE: Years will pass before medical view of 2020 is fully focused - The Times of Northwest Indiana

ECMC CEO and Jacobs School of Medicine Dean added to WNY COVID-19 vaccine hub leadership – WGRZ.com

BUFFALO, N.Y. Lieutenant Governor Kathy Hochul announced on Thursday that two areas leaders in medicine will join Catholic Health in leading the Western New York regional COVID-19 vaccine hub.

CEO of Erie County Medical Center, Tom Quatroche, and the University at Buffalo Jacobs School of Medicine Dean Dr. Michael Cain will lead the hub with Catholic Health CEO Mark Sullivan.

"Governor Cuomo and I are committed to helping ensure NY is the first state to eradicate COVID-19 with the distribution of vaccines to all who would like to receive it," said Hochul in a statement.

The hub is responsible for creating a regional COVID-19 vaccination plan and distributing the vaccine.

"We will continue to work hand in hand with county leaders, local health departments, and community groups to get the job done efficiently and effectively. The end is hopefully near," added Hochul.

Continued here:

ECMC CEO and Jacobs School of Medicine Dean added to WNY COVID-19 vaccine hub leadership - WGRZ.com

COVID-19 Vaccine Information and Update – University of Michigan Health System News

Which vaccines will be available?

Two vaccines have now received emergency use authorization from the FDA for their COVID-19 vaccines. On Friday, December 12, the FDA issued its authorization for individuals age 16 and older for the Pfizer vaccine, and on Friday, December 18, the vaccine produced by Moderna was approved by the FDA as well. Visit the Pfizer-BioNTech COVID-19 Vaccine page on the FDA website for more information about the Pfizer vaccine.

In addition, several other coronavirus vaccines are expected to be approved in the coming months. All vaccines approved for emergency use will have been reviewed for safety and effectiveness.

Michigan Medicines COVID-19 Vaccine & Therapeutics Task Force has identified the first groups to be vaccinated based on guidance from the Michigan Department of Health and Human Services (MDHHS). MDHHS follows Centers for Disease Control (CDC) recommendations based on input from the Advisory Committee on Immunization Practices (ACIP), a CDC advisory committee made up of medical and public health experts who develop recommendations on the use of vaccines in the United States.

The CDC and ACIP have defined populations for different vaccination phases:

The vaccine will be available to patients when supply substantially increases in 2021, possibly in late spring.See the chart above for the general phases of vaccine distribution.

The most efficient, convenient way for a Michigan Medicine patient to be notified when you are eligible to receive the COVID-19 vaccine is through our MyUofMHealth patient portal.

Based on information in your electronic medical record, you will receive a notification through the portal when you are eligible to receive the vaccine, and will be able to self-schedule your vaccine appointment directly through the portal.

Check your MyUofMHealth patient portal account now to be sure your email address is up to date and you are able to log in successfully. If you do not have an account, set one up today.

Patients who do not have active MyUofMHealth patient portal accounts will be contacted directly when they are eligible to receive the vaccine, but it is highly recommended that you set up a portal account for the most efficient, convenient way to be notified and schedule your appointment.

It is expected that pharmacies and local health departments will also begin offering the vaccine as supply is increased and the general public becomes eligible to receive the vaccine. We will update this page to help you understand your options for receiving the vaccine as more information becomes available.

Yes, the goal is to administer the initially limited supply of vaccines to those most at risk, following CDC guidelines for a phased rollout.

According to CDC, vaccination should be offered regardless of history of prior symptomatic or asymptomatic SARS-CoV-2 infection. Data from phase 2/3 clinical trials suggest vaccination is safe and likely efficacious in these people.

Current evidence suggests that people who have had COVID-19 may be protected for up to 90 days after their initial infection, so they may decide to wait until after this period, if desired.

Go to your study team coordinator with any questions you have about your eligibility to receive the COVID-19 vaccine once it becomes available.

Each vaccine uses a slightly different approach with the same goal: to induce an immune response in the body against SARS-CoV2, the virus that causes COVID-19. The vaccines produced by Pfizer and Moderna are both mRNA vaccines.

This type of vaccine operates somewhat differently than other types, like the seasonal flu vaccine. mRNA vaccines contain a message from the virus that causes COVID-19 and gives our cells instructions for how to make a harmless protein unique to the virus.

After our cells make copies of the protein, they destroy the genetic material from the vaccine. Our bodies recognize that the protein should not be there and build immune cells that will remember how to fight the virus that causes COVID-19 if we are infected in the future.

Most of the vaccines will require two shots, with the second shot received 21 to 28 days after the first, depending on the vaccine.

The Pfizer vaccine contains:

Side effects that have been reported with the Pfizer-BioNTech COVID-19 vaccine include:

More people experienced these side effects after the second dose than the first one. For more information, visit the FDA website's Pfizer-BioNTech COVID-19 Vaccine page.

Producing a vaccine against COVID-19 has been the top priority of scientists and governments around the world to help bring an end to the pandemic. With the coordinated and enormous investment of resources, development of these vaccines has been accelerated, all while maintaining standards for safety and efficacy.

Rather than eliminating steps from traditional vaccine development timelines, steps are proceeding simultaneously, such as scaling up manufacturing while safety and efficacy data are collected.

Before receiving approval for emergency use, pharmaceutical companies must provide evidence that their vaccines are safe. A team of experts from the FDA, CDCs Advisory Committee on Immunization Practices and other agencies reviewed all available data on safety and efficacy before recommending them for use.

Pregnant women and women trying to conceive were not included in the first round of clinical trials for the COVID-19 vaccines, so no safety data is currently available for these groups.

However, CDC recommends that pregnant women consider their personal risk of contracting COVID-19 by occupation or other activities, risk of COVID-19 to her and her pregnancy, efficacy of the vaccine, and known side effects of the vaccine when deciding whether to be vaccinated. Pregnant women and women trying to conceive should have a discussion with their healthcare provider about risks and benefits of the COVID-19 vaccine.

Health care professionals and researchers are still learning about COVID-19 and new information is discovered nearly every day that is helpful in the fight against this disease. Because COVID-19 is still a relatively new virus, it is difficult to know exactly how the virus affects the body long-term and how long immunity from natural infection lasts.

Therefore, it is also difficult to predict how long a vaccine will provide protection against the virus. As the vaccines are administered and new information is gathered, additional data about how long it will protect against the virus will be made available.

This is not known at this time. Scientists are continuing to collect data about long-term immunity to SARS-CoV2.

Based on our experience with other vaccines and early data from the COVID-19 vaccines, it is likely that people who are vaccinated will have enough immunity where they will not pass the virus to others if exposed, but this is not 100 percent certain.

Yes.While experts learn moreabout theprotectionthatCOVID-19 vaccines provide under real-life conditions, it will be importantforeveryoneto continue usingall the toolsavailable to us tohelpstop this pandemic, like covering your mouth and nose with a mask, washing hands often, and staying at least 6 feet away from others.Together, COVID-19 vaccination and following CDCs recommendations forhow to protect yourself and otherswill offer the best protection from getting and spreading COVID-19.

There is still more to learn about the protection that COVID-19 vaccines provide before deciding to change recommendations on steps everyone should take to slow the spread of the virus that causes COVID-19. Other factors, including how many people get vaccinated and how the virus is spreading in communities, will also affect this decision.

See the article here:

COVID-19 Vaccine Information and Update - University of Michigan Health System News

People of 2020: Kiran Mazumdar-Shaw ‘The Medicine Woman’ – The New Indian Express

KiranMazumdar-Shaw. 67Founder, Biocon

The founder of Biocon was not merelyproactive in speaking up against thegovernment when needed, but also in ensuring that Itolizumab, medication to battle psoriasis, was found effective in mitigating the cytokine storm of Covid-19

Indias richest self-made woman, with a net worth, according to Forbes, of $4.7 billion (`34,310 crore), is also one of its proudest and loudest. Refusing to shy away from controversy, she makes her views on government policies well known. Despite testing for Covid-19 herself, she kept her business going, all the while following the mantra that affordability is the bedrock of innovation.

Her Mazumdar Shaw Medical Foundation (MSMF) is the countrys first corporate hospital-based Technology Business Incubator, which hopes to kickstart 10 startups in the healthcare sector in 2021 in association with Dr Devi Shetty of Narayana Hrudayalaya.

She is also a globally recognised health expert, being on the panel of The Lancet Citizens Commission to develop a roadmap to achieve universal health coverage, and work towards ensuring access to quality and affordable healthcare to every Indian. Not bad for a businesswoman who discovered the medicinal properties of certain enzymes while brewing beer. Not surprisingly, her list of honours grows, whether it is the EY Entrepreneur of the Year or Australia's highest civilian honour in 2020.

Read the original here:

People of 2020: Kiran Mazumdar-Shaw 'The Medicine Woman' - The New Indian Express

Bomber to neighbour: World ‘never going to forget me’ – Medicine Hat News

By Kimberlee Kruesi, Denise Lavoie, And Michael Balsamo, The Associated Press on December 28, 2020.

NASHVILLE The man authorities believe was responsible for setting off a Christmas Day bomb that injured three people and damaged dozens of buildings in downtown Nashville told a neighbour days before the explosion that Nashville and the world is never going to forget me.

Rick Laude said he saw Anthony Quinn Warner standing at his mailbox on Dec. 21 and pulled over in his car to speak with him. After asking how Warners elderly mother was doing, Laude said he casually asked him, Is Santa going to bring you anything good for Christmas? Laude said Warner smiled and then said, Oh, yeah, Nashville and the world is never going to forget me.

Laude, 57, a commercial truck driver, said he didnt think much of the remark and thought Warner only meant that something good was going to happen for him. He said he was speechless later when he read that authorities had identified Warner as the suspected bomber.

Nothing about this guy raised any red flags, Laude said. He was just quiet.

THIS IS A BREAKING NEWS UPDATE. APs earlier story follows below.

With federal officials having identified the man believed to be behind Nashvilles Christmas Day bombing, authorities now turn to the monumental task of piecing together the motive behind the explosion that severely damaged dozens of downtown buildings and injured three people.

While officials on Sunday named Anthony Quinn Warner, 63, as the man behind the mysterious explosion in which he was killed, the motive has remained elusive.

We hope to get an answer. Sometimes, its just not possible, David Rausch, the director of the Tennessee Bureau of Investigation said in a Monday interview on NBCs Today show. The best way to find motive is to talk to the individual. We will not be able to do that in this case.

In just a few days, hundreds of tips and leads have been submitted to law enforcement agencies. Yet thus far, officials have not provided information on what possibly drove Warner to set off the explosion. According to officials, he had not been on the radar before Christmas. A TBI records report released Monday showed that Warners only arrest was for a 1978 marijuana-related charge.

It does appear that the intent was more destruction than death but again thats all still speculation at this point as we continue in our investigation with all our partners, Rausch added.

Furthermore, officials have not provided insight into why Warner selected the particular location for the bombing, which damaged an AT&T building and continued to wreak havoc on cellphone service and police and hospital communications in several Southern states as the company worked to restore service.

Forensic analysts were reviewing evidence collected from the blast site to try to identify the components of the explosives as well as information from the U.S. Bomb Data Center for intelligence and investigative leads, according to a law enforcement official who said investigators were examining Warners digital footprint and financial history, as well as a recent deed transfer of a suburban Nashville home they searched.

The official, who was not authorized to discuss an ongoing investigation and spoke to the AP on condition of anonymity, said federal agents were examining a number of potential leads and pursuing several theories, including the possibility that the AT&T building was targeted.

Korneski said Sunday that officials were looking at any and all motives and were interviewing acquaintances of Warners to try to determine what may have motivated him.

The bombing took place on a holiday morning well before downtown streets were bustling with activity and was accompanied by a recorded announcement warning anyone nearby that a bomb would soon detonate. Then, for reasons that may never be known, the audio switched to a recording of Petula Clarks 1964 hit Downtown shortly before the blast.

Warner, who public records show had experience with electronics and alarms and who had also worked as a computer consultant for a Nashville realtor, had been regarded as a person of interest in the bombing since at least Saturday, when federal and local investigators converged on the home linked to him.

Federal agents could be seen looking around the property, searching the home and the backyard. A Google Maps image captured in May 2019 had shown a recreational vehicle similar to the one that exploded parked in the backyard, but it was not at the property on Saturday, according to an Associated Press reporter at the scene.

On Sunday morning, police formally named Warner as being under investigation.

Officials said their identification of Warner relied on several key pieces of evidence, including DNA found at the explosion site. Investigators had previously revealed that human remains had been found in the vicinity.

In addition, investigators from the Tennessee Highway Patrol recovered parts from the RV among the wreckage from the blast, and were able to link the vehicle identification number to an RV that was registered to Warner, officials said.

Were still following leads, but right now there is no indication that any other persons were involved, Korneski said. Weve reviewed hours of security video surrounding the recreation vehicle. We saw no other people involved.

Police were responding to a report of shots fired Friday when they encountered the RV blaring a recorded warning that a bomb would detonate in 15 minutes. Suddenly the warning stopped, and Downtown started playing.

The RV exploded shortly afterward, sending black smoke and flames billowing from the heart of downtown Nashvilles tourist scene, an area packed with honky-tonks, restaurants and shops.

Buildings shook and windows shattered streets away from the explosion near a building owned by AT&T that lies one block from the companys office tower, a landmark in downtown.

But on Sunday, just blocks from where the bombing took place, tourists had already begun to fill the sidewalks on Lower Broadway, a central entertainment district. Some took selfies while others tried to get as close as possible to the explosion site, blocked by police barricades.

Earlier Sunday, the officers who responded provided harrowing details, at times getting choked up reliving the moments that led up to the blast.

This is going to tie us together forever, for the rest of my life, Metro Nashville police Officer James Wells, who suffered some hearing loss due to the explosion, told reporters at a news conference. Christmas will never be the same.

Officer Brenna Hosey said she and her colleagues knocked on six or seven doors in nearby apartments to warn people to evacuate. She particularly remembered a startled mother of four children.

I dont have kids but I have cousins and nieces, people who I love who are small, Hosey said, adding she had to plead with the family to leave the building as quickly as possible.

___

Balsamo and Tucker reported from Washington. Associated Press journalists Scott Stroud and Mark Humphrey in Nashville contributed to this report.

More:

Bomber to neighbour: World 'never going to forget me' - Medicine Hat News

Mired in crises, North Korea’s Kim to open big party meeting – Medicine Hat News

By Hyung-Jin Kim And Kim Tong-Hyung, The Associated Press on December 28, 2020.

SEOUL, Korea, Republic Of Coronavirus restrictions that have significantly limited his public appearances. Warning signals for an economy battered by pandemic-related border closings and natural disasters. The impending departure of a U.S. president who said he fell in love with him.

As North Korean leader Kim Jong Un grapples with the toughest challenges of his nine-year rule, hes set to open a massive ruling Workers Party congress next month to try to muster stronger public loyalty to him and lay out new economic and foreign policies.

While few question Kims grip on power, there is still room for things to get worse, especially if the world fails to find a quick way out of the COVID-19 crisis. That would prolong North Koreas self-imposed lockdown and could possibly set conditions for an economic perfect storm that destabilizes food and exchange markets and triggers panic among the public.

The congress, the first in five years, is the ruling partys top decision-making body. At the 2016 congress, Kim put himself in front, reaffirming his commitment to developing nuclear weapons and announcing an ambitious economic development plan. Five years later, experts say Kim doesnt have many options other than to further squeeze his populace for more patience and labour.

When we get into the specifics, theres really nothing new the North could present at the congress in terms of developing its economy, said Hong Min, an analyst at Seouls Korea Institute for National Unification. The country will continue to close its borders as long as the COVID-19 pandemic continues and the international sanctions will persist, so theres no visible room for a breakthrough.

Kim entered this year with a declaration of frontal breakthrough against punishing U.N. sanctions after his high-stakes diplomacy with President Donald Trump fell apart in 2019 over a U.S. refusal to offer extensive sanctions relief in return for limited denuclearization measures.

But Kims drive faced an immediate setback. Later in January, North Korea was forced to seal off its international borders, including one with China its biggest trading partner and aid benefactor after COVID-19 emerged there.

As a result of the border closure, North Koreas trade volume with China in the first 10 months of this year fell by 75%. That led to a shortage of raw materials that plunged the Norths factory operation rate to its lowest level since Kim took power in late 2011, and a four-fold price increase of imported foods like sugar and seasonings, South Koreas spy agency told lawmakers recently.

For several months, North Korea also restricted the use of U.S. dollars at markets, only to make its local currency, the won, appreciate sharply, triggering mounting public complaints. Authorities executed a high-profile currency trader in Pyongyang in October as a scapegoat, according to Ha Tae-keung, one of the lawmakers who was briefed by South Koreas National Intelligence Service, or NIS.

Lim Soo-ho, an analyst at an NIS-run think-tank , said North Korea likely aimed to reassert government control over markets amid the pandemic. He said such a step is doomed to fail because people are likely to exchange only a portion of their foreign currency savings for won in anticipation that the clampdown will eventually end.

Lim said if the COVID-19 pandemic continues for most of 2021, the Norths economy could face a crisis unseen since a devastating famine that killed hundreds of thousands of North Koreans in the 1990s.

During next months congress, North Korea will likely call for another frontal breakthrough to bolster its internal strength and build up a more self-reliant economy. But as long as the pandemic continues, the North will have to settle for modest economic goals while focusing on its anti-virus efforts, the Seoul-based Institute for Far Eastern Studies said in a report.

North Korea has steadfastly claimed to be coronavirus-free, though it said it has intensified what it called maximum anti-epidemic steps. Outside experts are highly skeptical of the Norths zero-virus case claim but agree the country hasnt experienced a widespread outbreak.

Why did they raise their anti-epidemic steps if they really havent had any patients? It doesnt make any sense, said Kim Sin-gon, a professor at Korea University College of Medicine in Seoul. But theyve imposed a higher level of anti-virus steps than any other country, so its likely that there arent many patients there.

North Koreas public healthcare infrastructure remains in shambles, with many hospitals still using equipment built in the 1960s and 1970s. This keeps North Korean officials vigilant because they know theyll suffer tremendous damage if they lower their guard even little bit, said Kang Young-sil, an analyst at Seouls University of North Korean Studies.

Since the pandemic began, North Korea has isolated people with suspected coronavirus symptoms, flown out foreign nationals and reportedly locked down one region after another. In some extreme measures detected by Seoul, the North banned fishing at sea, executed an official for violating regulations on the entrance of goods from abroad, and fatally shot and burned a South Korean official found floating on an object in waters near the Koreas disputed western maritime border.

North Korea is very sensitive and nervous amid the pandemic, and its making irrational, bizarre moves, said Nam Sung-wook, a professor at South Koreas Korea University.

Kim Jong Un, 36, has been hunkering down. Hes appeared in public 53 times this year to observe weapons tests, visit areas hit by typhoons and preside over high-level meetings, according to Seouls Unification Ministry, compared to an average of 103 appearances over the past four years.

Despite the deadlocked nuclear talks, North Korea likely hoped for the reelection of Trump, who met with Kim three times, giving him his long-desired legitimacy on a global stage. Trump once said he exchanged love letters with Kim and that we fell in love.

Instead of the top-down summitry used by Kim and Trump, President-elect Joe Biden will likely want working-level negotiators to sort out details and confirm North Koreas denuclearization commitment before he would meet with Kim. North Korea also is probably not an overriding priority for Biden, who faces several pressing domestic issues such as the coronavirus, an economy hammered by the pandemic, and racial disparities.

Some experts say North Korea may opt for its time-honoured strategy of conducting missile tests to draw U.S. attention like it did during past presidential transition periods in Washington. Others expect the North to avoid big provocations that could diminish the prospect for early talks with the Biden administration.

Satellite imagery provided by Maxar, a Colorado-based satellite imagery company, shows thousands of people assembled in formation at Pyongyangs main square on Saturday, likely rehearsing for upcoming celebrations. South Koreas spy agency earlier said North Korea would hold a military parade in January in a demonstration of its military strength targeting the Biden administration.

Kims government has acknowledged that the sanctions, the pandemic, and the typhoons and summer floods that wiped out crops have created multiple crises. But experts say China will help North Korea because it wont likely let its neighbour suffer a humanitarian disaster that could cause a refugee influx over their border.

Kim has been battered by a one-two punch the U.N. sanctions and the coronavirus pandemic, Nam said. But China is by his side and supporting him.

Excerpt from:

Mired in crises, North Korea's Kim to open big party meeting - Medicine Hat News

‘Covid-19 vaccine is medicine’s biggest win in 100 years’ – Pfizer boss Paul Reid urges Irish public to have faith in science – Independent.ie

On the face of it, it didn't seem much of a Christmas for Paul Reid. Not the Paul Reid who runs the Health Service Executive - although with Covid-19 case numbers soaring above 1,000 for the first time in two months, and a variant strain threatening to run amok, it can't have been much fun for him either.

is namesake holds the far more enviable position of Ireland manager of the company behind the most sought-after product in the world. This Paul Reid worked Christmas Eve, paused to gulp Christmas Day dinner and yesterday was up at the crack of dawn to go to his office in west Dublin. He wouldn't have had it any other way.

"This is a once-in-a-lifetime experience," said Reid, Pfizer Ireland's boss. "I would describe it as probably the biggest breakthrough we've had in 100 years in medicine. It really is that significant."

The first shipment of the eagerly awaited Pfizer-BioNTech Covid-19 vaccine landed on Irish soil yesterday morning. Two modest thermal shippers or boxes shipped in from the Continent. Five trays in each box, 195 vials in each tray and five doses in each vial enough for roughly 9,750 shots of vaccine.

The precious cargo was transported by road, with a discreet Garda presence, to the Health Service Executive's National Cold Chain Centre in Citywest.

There, the two Paul Reids, Health Minster Stephen Donnelly and a number of others were on site for the historic handover of the vaccine before the boxes were placed in one of the nine ultra-low temperature freezers the HSE bought last month.

A second delivery of around 30,000 doses arrives possibly as early as tomorrow or Tuesday. Ireland will have 40,000 doses by the end of next week and at least 30,000 doses a week each week after that, more as production ramps up.

"Effectively, we should have 40,000 doses by the end of December. Then there will be another shipment this week and another in the week of January 4, another January 11 and so on. We're going to get weekly shipments and the volumes are never committed to until much closer to the shipment days. But the expectation is that, you know, we'd be getting another approximately, you know, 32 trays, if you want to work that out in doses," he says on a video call on Christmas Eve.

The HSE declined to allow the media access to yesterday's event, citing security reasons. The vaccine is so coveted that the international police agency, Interpol, issued an orange notice recently warning governments that "criminal organisations" are "planning to infiltrate or disrupt supply chains".

Reid says he's never worked on a product like it. Pfizer has rebuffed numerous advances already. "Yes, I am aware [of approaches]," he laughs. A typical example, he says, are "private sector enterprises" that "would be very interested in getting their hands on a vaccine if it was available for commercial sale privately". They are turned away at the pass. "You don't even get to talk about money. You have to turn it away straight away. You can see the challenges of manufacturing this vaccine. It will only be available through contracted government agencies. That's going to be the way it is for the next six to eight months. Then we'll review how the vaccination roll-outs are going across Europe and the availability of doses beyond that date."

And no, Reid hasn't been vaccinated yet. He and his other Pfizer colleagues wait in line, in accordance with the Government's plan to vaccinate the most vulnerable first.

"You can imagine we get a lot of questions from our own manufacturing sites here, particularly, because they're essential workers, and they, I'm sure, would love to get the vaccine. But, no, we will fall in line with the guidelines coming from the National Covid-19 Vaccination Task Force," he says.

Pfizer can't produce the vaccine quick enough. As the first product to reach the market, Pfizer had anticipated making 100 million doses worldwide before the end of 2020, but revised that down to 50 million. Already rolled out in the UK and the US, European regulators approved the vaccine last Monday and shipments arrived in Germany, Italy and France as well as Ireland yesterday. Germany and Italy intend to start inoculating from today. Ireland will deliver its first jab on December 30 but the roll-out to nursing homes won't start until January 11.

The Pfizer vaccine is notoriously delicate. It must be stored and transported at minus 70C and comes with various shelf lives. It can last in an ultra-cool freezer for six months and in a regular fridge for five days. Once a vial is opened, the vaccine must be used within two hours. In order to ensure no drop of the vaccine is wasted, vaccinators and vaccines must be ready and waiting when it arrives. The vaccine itself must be administered in two doses, 21 days apart.

Pfizer will deliver direct to the HSE's storage depot in Citywest. After that, the HSE takes on the complicated logistics.

The HSE will ship the vaccine as needed around the country in "two to eight degree Celsius trucks and vans".

"They [the HSE] have autonomy to decide how much [vaccine] they remove from the ultra-low temperature refrigerators," he says. The HSE will have a deadline by which the vaccine must be used, "so they have to be very conscious of being able to get the right number of participants in, vaccinate them quickly, and then move on", he says.

If this sounds like a tall order, Reid points out that the HSE "has a lot of experience in Ireland" of moving vaccines.

Given the vaccine's accelerated production, there are many unknowns. Will the vaccine protect against the more transmissible UK strain of the coronavirus which the chief medical officer confirmed has reached Ireland?

"We don't know yet, but we have every reason to believe that the vaccine will be effective for the other variants of the virus," says Reid.

There is not enough data yet to show whether the vaccine can stop transmission. "So until we see the data, until we have the regulators' approval that the vaccine stops the transmission, you have to take all the other public health measures as well," he says.

We don't know either how long immunity will last - only time will tell on that one. Small numbers of people have had allergic reactions to the Pfizer-BioNTech vaccine, which has led to UK regulators issuing an advisory urging people with a history of allergic reactions not to get it.

Reid points out the vaccine will be given "under close medical supervision", saying: "Anyone who has a history of allergic reactions should not be given the vaccine. That will be in the licence."

The vaccine, like the virus it is targeting, is a work in progress, evolving as it goes.

"The main thing for us is we have a vaccine that works. It's 95pc effective - that's unbelievable. When you look at the efficacy, for nine-and-a-half out of 10 people, it's going to be effective. That's across all participants - irrespective of age, gender, race, ethnicity. You're going to see the same efficacy. And it's safe as well," says Reid.

Reid adds the biggest challenge for the health authority is winning public trust.

"I would say one of the big bits of work we have to do as a country, and certainly for the HSE, is trying to ensure that people are confident to take the vaccine.

"We can't really afford to be hesitant, given the critical situation of the pandemic. Anyone who decides not to vaccinate are not just deciding for themselves - their decisions will also impact on their families and loved ones who live with them. I would certainly say if you have an opportunity to be vaccinated, you should take it.

"Trust the science. Trust the experts. If they're recommending this is effective and safe to use, that's good enough for me."

Originally posted here:

'Covid-19 vaccine is medicine's biggest win in 100 years' - Pfizer boss Paul Reid urges Irish public to have faith in science - Independent.ie

Saudi women’s rights activist sentenced to nearly 6 years – Medicine Hat News

By Aya Batrawy, The Associated Press on December 28, 2020.

DUBAI, United Arab Emirates One of Saudi Arabias most prominent womens rights activists was sentenced on Monday to nearly six years in prison under a vague and broadly-worded law aimed at combating terrorism, according to state-linked media.

Loujain al-Hathlouls case, and her imprisonment for the past two and a half years, have drawn international criticism from rights groups, members of the U.S. Congress and European Union lawmakers.

State-linked Saudi news outlet Sabq reported that al-Hathloul was found guilty by the kingdoms anti-terrorism court on charges including agitating for change, pursuing a foreign agenda and using the internet to harm public order. She has 30 days to appeal the verdict.

Al-Hathloul was among a handful of Saudi women who openly called for the right to drive before it was granted in 2018 and for the removal of male guardianship laws that had long stifled womens freedom of movement and ability to travel abroad.

Here is the original post:

Saudi women's rights activist sentenced to nearly 6 years - Medicine Hat News

UTRGV to offer 10th school of podiatric medicine in entire nation – KGBT-TV

EDINBURG, Texas (KVEO) UTRGVSSchool of Medicineis growing againbyaddingapodiatry program the only one inTexas.

Historically, anyone inTexaswho wanted to be a podiatrist had to leave the state to get a degree to come back,Dr. Lawrence Harkless,UTRGV School of Podiatry interim dean said.

Dr.Harkless came out of retirementto serve as the new schools deanand prepare the academic plan.

We will be taking the classes the medical school takes in the first two years,and then we will start teaching more podiatry-specific courses earlier,he said.

Dr. Harkless previously helped establish aCollege ofPodiatricMedicine inPomona,California, and saysstudent mentorship will be at the forefront of this new program.

The foundation for that would be learn, serve, lead,he said.

According to theAmericanDiabetesAssociation, theRGV has a diabetes rate three times higher than the national average, whichDr.Harkless says makes the area an ideal spot fortheschool.

(People) Can really stay inthecommunity where they grewup andserve,he said.

The inaugural class will be welcomed in the fall of 2022,andUTRGVisalready looking to hire 20 faculty with a passion for both teaching as well as research.

Tohaveexcellence in a student, every faculty member has to be excellentbecause they have to be able to teach thatwhetherin basic science, two years theory andfactorwhetherin clinical years, he said.

Along with theSouthTexasDiabetes andObesityInstitute ofBrownsville,Dr.Harkless says theRGV could become medical leaders over genetics and genomics of the feet.

Read the original here:

UTRGV to offer 10th school of podiatric medicine in entire nation - KGBT-TV

Burnout: The Experience of Women In Medicine During COVID-19 – The Doctor Weighs In

Women in medicine are at risk of physician burnout due to COVID-19 due to many different factors, including:

Further, they must continue to deal with all of the job-related stress that existed before the pandemic, including:

No wonder women in medicine are feeling overwhelmed and are at risk of burnout.

Since the onset of COVID-19, people worldwide have had to learn to adapt to change quickly. The problem with this, however, is that our brain doesnt like change. It likes to predict the future and when we face change, this means one thing: uncertainty.

The pandemic has turned the world as we knew it upside-down. Things we previously took for granted, like getting together with friends or going to work, became risky.

In addition to dealing with the possibility of contracting COVID through everyday activities, medical professionals are also at increased risk of contracting the virus through the treatment of their sick patients.

Related Content:Survey Shows Women in Medicine Still Face InequitiesPrioritizing Healthcare Workers Mental Health During COVID-19

While they are needed now more than ever, medical professionals are losing their jobs and experiencing a reduction in pay and hours. Those who have not yet been affected are worried about the future of their career and financial stability.

Because most schools in the United States have switched over to a digital format, much of childcare and homeschooling have fallen on parents. Traditionally, women have been the primary ones to handle work within the home. [3] Therefore, it is not a far stretch to imagine that they are also the ones who are taking on most of these domestic tasks now.

While these women might be high achievers, many say they are working hard for their families. The trouble is their career takes up so much of their time that they have less time to spend with their loved ones. Even when they have the time, they often experience emotional exhaustion, [4] which may keep them from being fully present.

Perhaps, that is why 40 percent of female physicians end up leaving or cutting back their hours by their sixth year [5]. A similar trend can be seen with female nurses whose turnover rates are purported to be as high as 38 percent.[6] However, working less can bring up additional stress related to paying back student loans and other financial debt.

For all these reasons, being a woman in medicine now more than ever can feel like being in survival mode. Indeed, when demands are excessive and resources are short, this is a recipe for burnout [7].

As it turns out, 42 percent of physicians reported being burned out according to a recent online survey [8]. A similar trend can be seen with nurses who normally experience emotional pressures in their jobs which, during a pandemic, can lead to stress and burnout. [9]

When these professionals are not at their best, they suffer a decrease in energy, morale, and job performance. And, the quality of their medical care goes down.

The effect of this trickles down to patients who receive poorer quality care. And they may suffer higher rates of infections and increased mortality rates due to medical errors. [10]

Some women in medicine may turn to junk food or overindulge in drugs or alcohol to cope with stress. Such maladaptive coping translates into weight gain, poorer health, and addictions. All of these things have further consequences that negatively affect sleep, mood, and relationships.

While the external stressors they face are real, it is up to the individual to learn to manage their thinking to avoid feeling anxious, overwhelmed or burned out. This is possible even during COVID-19.

In addition to environmental stressors, part of the reason why anxiety and burnout are an epidemic among healthcare workers is because of the stigma around mental health in the field of medicine.

There is an expectation that healthcare providers are superhuman. And, that they can manage to deal with emotionally draining and sometimes traumatic experiences while navigating challenging work-related conditions without being affected. This is clearly unrealistic and very damaging to their long-term well-being.

Nevertheless, not all hope is lost. The key to staying afloat amid the chaos is self-management. It may seem that the reasons for the stress are external factors and therefore beyond your control. However, our response to stress is a product of our minds.

Think of a time when you were in the same situation as someone else. While you may have been negatively affected by the circumstances at the time, your friend or colleague was unphased.

The reason for this difference in outcomes relates to perception. It is not what happens to us that makes us feel how we do. Rather, it is how we think about what happens to us that leads to those feelings.

When we misunderstand someones intention, we can feel upset by our interpretation. Once we realize what they truly meant, our perception shifts. Consequently, so do our feelings.

The same is true in the workplace. It is your thinking that creates your current emotional state, not the circumstances. When you shift your mindset, you shift your anxiety into a state of calm.

The next time you find yourself ruminating about mistakes youve made or worrying about the future, bring yourself back to the present moment. Recognize that you have a choice about where you focus your mind.

The world around you will remain imperfect. The healthcare system in which you work will continue to be deeply flawed.

When you fixate on what should be different, youll only feel frustrated. Instead, focus inward on what you can control. This is because the only thing you have control over is yourself.

By learning to manage your thinking, you can make positive changes, such as:

The responsibility of self-management and self-care may seem like an added burden to your already burdened life. However, by increasing Emotional Intelligence and managing your energy, you lighten your load.

What may have seemed overwhelming previously may feel easier when your perspective shifts, when you are in a state of balance, and when you are able to accept aspects that exist outside your control.

You are stronger than you realize and no matter what, rememberyou always have a choice.

During the COVID-19 pandemic, women in medicine have been faced with heightened demands and lower than normal resources. This combination can overwhelm and bring about anxiety and burnout.

By focusing internally rather than externally, you can regain control over your reactions and refocus on what really matters long-term.

Follow this link:

Burnout: The Experience of Women In Medicine During COVID-19 - The Doctor Weighs In

Meet the power couple who are changing the face of veterinary medicine – Jill Lopez

Dr. Valerie Marcano and Dr. Seth Andrews are more than just a couple in love, together they are working to make veterinary medicine more diverse - something that the veterinary profession desperately needs help with. In 2013, the profession of veterinary medicine was named the whitest profession by The Atlantic magazine. This report mirrored another report in the Journal of Blacks in Higher Education, which gave veterinary medicine the designation as most segregated of all the health professions.

Dr. Valerie completed her DVM and PhD at the University of Georgia ((2017 and 2020) and is a Poultry Technical Consultant at Elanco Animal Health as well as the chair of the Diversity and Inclusion Committee of the American Association of Avian Pathologists.

Dr. Seth Andrews, the other half of the team, is a Process Engineer with Precision BioSciences. He completed a post-doc at the University of Georgia after earning his PhD in Biological Engineering from the University of Georgia in 2019. He received his Bachelor of Science and Master of Engineering from Cornell University.

As fate would have it, he would meet Valerie at Cornell University. They were both a member of Cornells Alpha Zeta fraternity. Valerie made fun of Seth for eating his pizza with a knife and a fork, but it ended up working out as a beautiful relationship.

Together they created Pawsibilities Vet Med - a web and mobile platform designed to aid in the recruitment and retention of diverse students in the veterinary profession through resources, discussion forums and the showcasing of diverse veterinarians. Pawsibilities aims to connect individuals from underrepresented backgrounds interested in the veterinary profession to both opportunities available and to potential mentors and advisors within the field through a mentorship platform.

Pawsibilities Vet Med pools available resources and provides information about veterinary medicine to educate students about the myriad of paths they may take within the profession. It also provides a forum to discuss the various challenges and pitfalls on the path to becoming a veterinarian or veterinary technician. Pawsibilities Vet Med also showcases veterinarians and veterinary technicians from a variety of backgrounds, to emphasize that anyone from anywhere can join the profession.

Together, they hope to give people of color an easier path into veterinary medicine, while also enriching the lives of those who have already made it and providing them the care they need. Their work is the perfect example of how veterinarians should be and also what the future can look like if more people think and act like them.

We caught up Dr. Valerie to learn more:

How we met

We met while attendingCornell Universitys Alpha Zeta fraternity during the Fall of 2009. We were both Sophomores.Its a funny story but essentially I made fun of Seth for eating pizza with a fork and knife.

Who DTR (defined the relationship)

I did!

Secrets to working with your spouse

Our secret to working with each other is having lots of patience and utilizing each others strengths. Seth is really good with website design and technical issues, while I am very good at coming up with ideas.

Best part of working together: Being able to communicate when you have ideas and often being on the same page

Worst part of working together:

Talking about work all the time - sometimes we feel like we need to keep working and if we are doing something fun, we feel like we should be working instead. We often have to remind each other that it is ok to take a night off.

Who I admire most and why:

I have a number ofveterinary women that have truly been my rock and inspiration - trailblazers in the profession that have paved the path I walk on. I remember my first visit to the University of Georgia and meeting Dr. Paige Carmichael, at the time the Associate Dean for Academic Affairs, and Dr. Kaori Sakamoto, at the time the Program Coordinator for the UGA College of Veterinary Medicine's Veterinary Medical Scientist Training dual DVM-PhD degree program. I remember being in awe of these highly trained dual board certified DVM and PhD women of color and have been truly fortunate to have had them become mentors and friends.

Best advice I ever received:

Keep your options open. I was set on a specific job after graduation and one of my mentors, and the person who would have been my supervisor in that position told me to keep my options open. I did and have not regretted it one bit.

Why it is time for Pawsibilities Vet Med:

Because diversity promotes growth - within individuals and the profession as a whole. Diversity, paired with proper training in equity and inclusion, brings about wellness in our profession. Mentorship constitutes support - a clan, a village. It supports the concept that we stand on the shoulder of giants and gives us the chance to pave an even better path for those before us.

Looking to advance or start your career in veterinary medicine? Want to give back to the future of veterinary medicine? Both? Sign up here!

Pawsibility Vet Med

Go here to see the original:

Meet the power couple who are changing the face of veterinary medicine - Jill Lopez